CuB prevents proliferation and invasion in human glioblastoma multiforme (GBM) cell lines, in addition to downregulating the expression of the oncoprotein CIP2A and its downstream signaling molecule phospho-Akt, suggesting that CuB could be a potential inhibitor of CIP2A. Here, AKT1 is linked to glioblastoma.